Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

Inclusion Criteria: * 18 year old ≤ Male or female \< 75 year old * Patients who had endoscopically confirmed Gastric and/or duodenal ulcer and H.pylori infection confirmed by Urea Breath Test * Patients who understand the study conditions * Patients who had been given the explanation about the study, and had provided voluntary written informed consent to participate in the stud Exclusion Criteria: * Patients with known allergy or hypersensitivity reaction to the Investigational products * Patients who use the Investigational products * Patients who undergone H.pylori eradication * Patients with abnormal laboratory results, as specified below: Total bilirubin, creatinine \> 1.5 x upper limit of normal Aspartate transminase, Alanine transminase, Alkaline phosphatase, Blood urea nitrogen \> 2 x upper limit of normal * Patients who used Proton Pump Inhibitor agents or antibiotics within the last 2 weeks before the start of the Investigational products * Pregnant women and lactating women * Women of childbearing potential who were not using a medically acceptable method of contraception during the study period.(Menopausal women who did not have a menstrual period for at least 12 months were considered infertile) * Patients with uncontrolled Diabetes mellitus * Patients with uncontrolled Hypertension * Patients with Alcoholics * Patients with a history of malignancy within 5 years prior to the study entry (Day 1) (except for basal cell carcinoma of the skin) * Patients who had undergone a esophageal or gastric surgery * Patients who had a hereditary disorder as galactose intolerance, lactose intolerance, glucose-galactose malabsorption * Patients who had participated in other investigational study within 30 days before the study entry (Day 1) * Patients who, in the investigator's opinion, are not suitable for the study for any other reason